Prescription drug · ANDA
Zileuton NDC 64980-206
Zileuton 600 mg/1 · Tablet, Extended release · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64980-206-12 | 64980020612 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12)Marketed from Mar 21, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zileuton
- Generic name (nonproprietary)
- zileuton
- Active ingredients
- Zileuton — 600 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 64980
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204929
- Marketing start
- Listing expires
- Other FDA classes
- 5-Lipoxygenase Inhibitors (Mechanism)Decreased Leukotriene Production (Physiologic effect)
- Identifiers
- Product ID 64980-206_984587a3-4875-4ad3-af6e-11b90fe705a8SPL ID 984587a3-4875-4ad3-af6e-11b90fe705a8SPL set ID fd382540-b390-4e86-a94a-988ea89c93a8RxCUI 730834UNII V1L22WVE2S
- Pharmacologic class
- 5-Lipoxygenase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464980020612followed by a unit qualifier and the quantityPackage 64980-0206-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Zileuton Extended-Release Tablets is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. Zileuton Extended-Release Tablets are not indicated for use in the reversal of bronchospasm in acute asthma attacks. Therapy with Zileuton Extended-Release Tablets can be continued during acute exacerbations of asthma. Zileuton Extended-Release Tablets is a leukotriene synthesis inhibitor indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. ( 1 ) Do not use Zileuton Extended-Release Tablets to treat an acute asthma attack. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 64980-206
- What is NDC 64980-206?
- 64980-206 is the product NDC for Zileuton, Zileuton 600 mg/1 tablet, extended release, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zileuton.
- What is the active ingredient?
- Zileuton.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zileuton?
- 4 other product NDCs are listed under this name. See all Zileuton NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zileuton products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zileuton | Zileuton 600 mg/1 | Tablet, Film coated, Extended releaseOral | NorthStar RxLLC | 72603-246 | 72603-0246-01 |
| Zileuton | Zileuton 600 mg/1 | Tablet, Multilayer, Extended releaseOral | Strides Pharma Science Limited | 64380-189 | 64380-0189-01 |
| Zileuton | Zileuton 600 mg/1 | Tablet, Film coated, Extended releaseOral | Camber Pharmaceuticals, Inc. | 31722-044 | 31722-0044-12 |
| Zileuton | Zileuton 600 mg/1 | Tablet, Multilayer, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-741 | 51407-0741-12 |